B
Biodexa Pharmaceuticals Plc
Q4 2024 earnings expected
Quarter
Oct – Dec
Expected
March 1, 2025(ET)
EPS
This quarter-$905.39
Year ago (Dec '23)-$149016.80▲ +99.4%
Revenue Growth Trajectory
-62%YoY
Last 6 quarters · 1 analysts
Biodexa Pharmaceuticals Plc
Oct – Dec
March 1, 2025(ET)
Last 6 quarters · 1 analysts